Popular Trials
Tyrosine Kinase Inhibitor
Sunitinib vs Cediranib for Sarcoma
Recruiting1 awardPhase 2
Santa Monica, California
This trial is testing the effects of two drugs, cediranib and sunitinib, on patients with a rare cancer called alveolar soft part sarcoma. The trial will see if either of the drugs help to shrink the tumors, and if so, which drug works better.
Popular Filters
Phase 3 Trials
Kinase Inhibitor
Ripretinib vs Sunitinib for Gastrointestinal Stromal Tumors
Recruiting3 awardsPhase 3
Scottsdale, Arizona
This trial is comparing the effectiveness of ripretinib to sunitinib in patients with gastrointestinal stromal tumors (GIST) who did not respond well to their first treatment with imatin
Checkpoint Inhibitor
Nivolumab + Cabozantinib for Kidney Cancer
Recruiting2 awardsPhase 3
Daphne, Alabama
This trial will test whether a combination of nivolumab and cabozantinib is safe and effective in treating people with previously untreated advanced or metastatic renal cell carcinoma, compared to sunitinib.
Kinase Inhibitor
Savolitinib vs. Sunitinib for Kidney Cancer
Recruiting2 awardsPhase 3
La Jolla, California
This trial is for patients with a certain type of kidney cancer that has spread and cannot be removed by surgery. The goal is to see if a new medication, savolitinib, is better than the current standard of care, sunitinib, and to learn about any side effects.
Trials With No Placebo
Tyrosine Kinase Inhibitor
Targeted Therapy for Advanced Stage Cancer
Recruiting1 awardPhase 2
Birmingham, Alabama
This trial is studying how well different targeted drugs work in treating patients with cancer that has progressed after other treatments and has a genomic variant that makes the tumor respond to the drug.
Tyrosine Kinase Inhibitor
Sunitinib + Valproic Acid for Uveal Melanoma
Recruiting2 awardsPhase 2
Philadelphia, Pennsylvania
This trial compares sunitinib malate to valproic acid in preventing uveal melanoma from spreading. Sunitinib malate may stop growth signals into tumor cells and prevent them from growing. Valproic acid may change some genes in uveal melanoma and suppress tumor growth.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.